Silymarin (milk thistle) for liver support in animals
Silymarin (milk thistle) for liver support in dogs and cats: evidence, safety and when a vet is required.
Short & honest
Silymarin is widely used for liver support in dogs and cats, but clinical evidence is limited (grade C): mechanisms are promising in the lab, but convincing practical studies are still largely lacking.
Safety assessment: Safe when used correctly
Veterinary review not yet completed
This page is awaiting review by a registered veterinary surgeon. Until then, treat the text as education based on the sources listed — not as a verified veterinary judgement.
What is silymarin?
Silymarin is the group of active substances from the fruits of milk thistle (Silybum marianum). It contains several related flavonolignans, of which silybin is the best studied and most bioactive component. In veterinary herbal medicine, silymarin is traditionally used as liver support; it is also available in combined dietary supplements for dogs and cats, sometimes together with SAMe or other liver-supporting substances [2].
Claims versus evidence
The following properties are attributed to silymarin:
- hepatoprotective — protection of liver cells against harmful substances
- antioxidant — neutralisation of free radicals
- anti-inflammatory and antifibrotic — inhibition of scar formation in liver tissue
Under laboratory conditions and in laboratory animals, these mechanisms have indeed been described [1]. The clinical translation to the living dog or cat, however, has not yet been convincingly demonstrated.
The available literature consists largely of narrative reviews without controlled comparison [1][2][4]. The only randomised clinical trial (RCT) available in the veterinary literature did not test pure silymarin but a combination product — silybin combined with SAMe (Denamarin) — as prevention of liver damage caused by the chemotherapeutic agent CCNU in dogs with cancer. That product did not prevent liver damage significantly better than placebo [3]. This illustrates how difficult it is to isolate the contribution of silymarin separately, and how sparse the clinical evidence base currently is.
Evidence grade: C — weak evidence.
For which complaints and animal species?
Silymarin is most commonly considered in dogs and cats for:
| Application | Dog | Cat |
|---|---|---|
| Chronic liver diseases | Limited evidence [1][4] | Very limited [4] |
| Liver toxicity due to medication or poisons | Mechanistically plausible [1] | Mechanistically plausible [1] |
| Prevention of liver injury during chemotherapy | Not demonstrated [3] | No data |
In cats, the evidence is thinner than in dogs: species-specific clinical studies are almost entirely lacking [4]. Cats metabolise certain plant compounds differently from dogs, which justifies extra caution.
Safety
Silymarin is considered generally well tolerated in dogs and cats at common supplement dosages [2]. Reported adverse effects are rare and mild:
- mild gastrointestinal complaints
- looser stools at higher dosages
Special points of attention:
- Quality and active substance content vary greatly between supplement brands; there is no legal guarantee of bioavailability.
- Use in an animal with an already diagnosed liver disease always requires veterinary supervision.
- Silymarin does not replace diagnostics. Liver complaints can have various causes that require targeted treatment.
Concrete dosages are deliberately not stated on this page. The veterinary surgeon determines what is appropriate based on weight, condition and any concomitant medication.
When to call a veterinary surgeon immediately?
See the red flags below. Liver complaints in animals can become serious quickly and require diagnosis, not a supplement.
Why this verdict?
The evidence consists mainly of narrative reviews [1][2][4] describing mechanistically plausible hepatoprotective effects, but allowing no firm clinical conclusions. The only available RCT tested not pure silymarin but a combination product (silybin + SAMe) in dogs during chemotherapy, and showed no significant advantage over placebo [3]. The absence of controlled clinical trials with silymarin as a single substance in dogs or cats justifies grade C: weak evidence.
Interactions with medication
- CYP450 enzymes: silymarin can inhibit enzymes involved in the breakdown of various medicines, including antiepileptics (such as phenobarbital) and certain antibiotics — this can increase the blood levels of those agents
- Chemotherapeutics: interaction described in a clinical context, without proven benefit [3]
- Other liver-supporting supplements (SAMe, ursodeoxycholic acid): combined use is common in practice but has not been systematically evaluated
Legal status (Netherlands)
In the Netherlands, silymarin products for animals fall under the category **feed supplements**. Therapeutic claims — such as 'treats liver disease' — are not permitted without registration as a veterinary medicinal product. Treatment advice is legally reserved for veterinary surgeons (Wet Dieren, art. 2.11).
Sources
- [1] Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease (Hackett et al.). J Vet Intern Med, 2013. Narrative review doi:10.1111/jvim.12002
- [2] Silymarin (Milk Thistle) - Veterinary Partner (VIN). Veterinary Partner / VIN. Narrative review source ↗
- [3] Prospective Randomized Clinical Trial Assessing the Efficacy of Denamarin for Prevention of CCNU-Induced Hepatopathy in Tumor-Bearing Dogs. J Vet Intern Med (Skorupski et al.), 2011. RCT doi:10.1111/j.1939-1676.2011.0743.x
- [4] Evidences on Molecules Most Frequently Included in Canine and Feline Complementary Feed to Support Liver Function. PMC, 2020. Narrative review source ↗
Questions about this substance for your animal?
Stuck in the information, or unsure whether a remedy is right for your animal? Send us a message. We sell nothing and give no treatment advice, but we are happy to think along — for instance in finding reliable sources or preparing your question for the vet.